Nanomerics
Pharmaceutical Manufacturing • 
Wembley, England, United Kingdom • 1-10 Employees
Company overview
| Headquarters | Block Y, Northwick Park and St Mark’s Hospital, Watford Road, Harrow, London HA1 3UJ, GB |
| Phone number | +442033972183 |
| Website | |
| NAICS | 3254 |
| SIC | 283 |
| Keywords | Drug Delivery, Pharmaceutical Nanotechnology, Formulation And Bioanalytical Services |
| Founded | 2010 |
| Employees | 1-10 |
| Socials |
Key Contact at Nanomerics
Ilona Kubajewska
Director Of Preclinical Research & Development
Nanomerics Email Formats
Nanomerics uses 4 email formats. The most common is {first initial}.{last name} (e.g., j.doe@nanomerics.com), used 42.9% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@nanomerics.com | 42.9% |
{first name}.{last name} | john.doe@nanomerics.com | 28.6% |
{first initial} | j@nanomerics.com | 14.3% |
{first name} | john@nanomerics.com | 14.3% |
About Nanomerics
Nanomerics uses its world-leading pharmaceutical nanotechnology to develop new medicines faster, cheaper, and with dramatically reduced risk. Nanomerics proprietary technology boosts the activity of hydrophobic drugs and peptides by getting them where they need to be. This allows the creation of new medicines based on known drug compounds that now can be given in new ways and for new indications. Nanomerics’ Molecular Envelope Technology (MET) is applicable to a broad range of compounds and allows targeting of diseases via the oral and nasal route, delivery to the eye, and across the blood-brain-barrier. Nanomerics offers its medicines development capability and expertise to partners wanting to enable specific drugs, e.g. the company is currently working with a NSADAQ company on two oral products and an Asian company on nasal delivery. Nanomerics also develops its own nano-enabled medicines and has products targeting the ophthalmic market as well as oral medicines e.g. in the area of oncology. Its lead product is a peptide for the treatment of chronic pain. The endogenous peptide is already known to be efficacious and safe. Combination with the MET system creates a nano-enabled medicine that avoids some of the significant problems of current opioid drugs.
Nanomerics revenue & valuation
| Annual revenue | $684,440 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $2,200,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Nanomerics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Nanomerics has never raised funding before.
Nanomerics Tech Stack
Discover the technologies and tools that power Nanomerics's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Issue trackers
Appointment scheduling
Blogs
Miscellaneous
Security
Miscellaneous
JavaScript frameworks
IaaS
CDN
Reverse proxies
Miscellaneous
Brazil
Canada
United States
Frequently asked questions
4.8
40,000 users
